Charles J. Homcy
Director, MILLENNIUM PHARMACEUTICALS INC.
Companies
- Maze Therapeutics, Inc.Board member Jan 30, 2025 to now1
- BridgeBioBoard member Mar 3, 2021 to now2
- Pliant (United States)Board member Jun 2, 2020 to Jun 30, 20213
- Population Health Investment Co., Inc.Board member Nov 17, 2020 to Jan 26, 20214
- BridgeBioChair Jun 27, 2019 to Oct 19, 20205
- Global Blood Therapeutics, Inc.Board member Aug 11, 2015 to Jun 22, 20186
- CephalonBoard member Mar 14, 2011 to Oct 17, 20117
- Geron CorporationBoard member May 26, 2006 to May 13, 20118
- CytokineticsBoard member May 26, 2006 to May 27, 20089
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
BridgeBio BBIO919,876 shares10$62.7M at $68.14Jun 22, 2026- Maze Therapeutics, Inc. MAZE38,535 shares11$1.2M at $30.36May 4, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 22, 2026Granted 3,990 shares of BridgeBio10
- Jun 20, 2026Shares withheld for tax 788 shares at $66.27 of BridgeBio12
- May 4, 2026Gift 7,422 shares of Maze Therapeutics, Inc.11
- Nov 19, 2025Other 1,489 shares of Maze Therapeutics, Inc.13
- Oct 23, 2025Gift 28,423 shares of Maze Therapeutics, Inc.14
- Aug 11, 2025Sold 50,000 shares at $48.00 of BridgeBio15
- Aug 8, 2025Sold 58,338 shares at $46.64 of BridgeBio15
- Aug 8, 2025Sold 191,662 shares at $45.87 of BridgeBio15
- Jun 27, 2025Gift 20,000 shares of BridgeBio16
- Jun 20, 2025Granted 6,589 shares of BridgeBio17
- Feb 3, 2025Converted 7,422 shares of Maze Therapeutics, Inc.18
- Feb 3, 2025Converted 20,717 shares of Maze Therapeutics, Inc.18
- Feb 3, 2025Converted 8,807 shares of Maze Therapeutics, Inc.18
- Feb 16, 2024Shares withheld for tax 1,509 shares at $37.21 of BridgeBio19
- Feb 16, 2024Exercised options 3,760 shares of BridgeBio19
- Nov 16, 2023Shares withheld for tax 1,301 shares at $28.86 of BridgeBio20
- Nov 16, 2023Exercised options 3,760 shares of BridgeBio20
- Aug 16, 2023Shares withheld for tax 1,301 shares at $29.80 of BridgeBio21
- Aug 16, 2023Exercised options 3,760 shares of BridgeBio21
- May 16, 2023Shares withheld for tax 1,300 shares at $14.09 of BridgeBio22
- May 16, 2023Exercised options 3,759 shares of BridgeBio22
- Feb 16, 2023Shares withheld for tax 1,534 shares at $12.64 of BridgeBio23
- Feb 16, 2023Exercised options 3,760 shares of BridgeBio23
- Nov 16, 2022Shares withheld for tax 1,301 shares at $9.64 of BridgeBio24
- Nov 16, 2022Exercised options 3,760 shares of BridgeBio24
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARBridgeBio, Board member
- 3SEC EDGARPliant (United States), Board member
- 4
- 5SEC EDGARBridgeBio, Chair
- 6
- 7SEC EDGARCephalon, Board member
- 8SEC EDGARGeron Corporation, Board member
- 9SEC EDGARCytokinetics, Board member
- 10
- 11
- 12SEC EDGARForm 4 filed Jun 23, 2026
- 13SEC EDGARForm 4 filed Nov 21, 2025
- 14SEC EDGARForm 4 filed Oct 27, 2025
- 15SEC EDGARForm 4 filed Aug 12, 2025
- 16SEC EDGARForm 4 filed Jun 30, 2025
- 17SEC EDGARForm 4 filed Jun 24, 2025
- 18SEC EDGARForm 4 filed Feb 4, 2025
- 19SEC EDGARForm 4 filed Feb 21, 2024
- 20SEC EDGARForm 4 filed Nov 20, 2023
- 21SEC EDGARForm 4 filed Aug 18, 2023
- 22SEC EDGARForm 4 filed May 18, 2023
- 23SEC EDGARForm 4 filed Feb 21, 2023
- 24SEC EDGARForm 4 filed Nov 18, 2022